Search for Clinical Trial Results

Glucose Transporter Type 1 Deficiency Syndrome - 13 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Condition: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Date: 2013-10-31 Interventions:
|
Recruiting |
Study Name: An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome Condition: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS) Date: 2014-01-13 Interventions: Drug: Triheptanoin Schedule A: Subjects previously treated |
Recruiting |
Study Name: Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Condition: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Date: 2016-11-07 Interventions:
|
Enrolling by invitation |
Study Name: Study to Assess the Long Term Safety and Efficacy of UX007 in Subjects With Glucose Type 1 DS Condition: Glucose Transporter Type 1 Deficiency Syndrome Date: 2015-11-03 Interventions: Drug: UX007 UX007 is a liquid intended for oral (PO) administration. |
Recruiting |
Study Name: Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS Condition: Glut1 Deficiency Syndrome Date: 2013-12-03 Interventions: Drug: GLUT1 DS |
Active, not recruiting |
Study Name: Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome Condition: Glucose Transporter Type 1 Deficiency Syndrome Date: 2013-11-27 Interventions: Drug: Triheptanoin Triheptanoin (C7 oil) is a triglyceride of the anaplerotic odd-chain fatty acid hepto |
Not yet recruiting |
Study Name: Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) Condition:
|
Completed |
Study Name: Evaluation of Keyo in Children With Epilepsy Condition:
|